P. C. Gaskell

514 total citations
8 papers, 400 citations indexed

About

P. C. Gaskell is a scholar working on Molecular Biology, Physiology and Genetics. According to data from OpenAlex, P. C. Gaskell has authored 8 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Physiology and 3 papers in Genetics. Recurrent topics in P. C. Gaskell's work include Alzheimer's disease research and treatments (5 papers), Dementia and Cognitive Impairment Research (3 papers) and Genetic Associations and Epidemiology (2 papers). P. C. Gaskell is often cited by papers focused on Alzheimer's disease research and treatments (5 papers), Dementia and Cognitive Impairment Research (3 papers) and Genetic Associations and Epidemiology (2 papers). P. C. Gaskell collaborates with scholars based in United States and Canada. P. C. Gaskell's co-authors include Allen D. Roses, James R. Burke, Barbara J. Crain, MA Pericak-Vance, Christine Hulette, C. Rosenberg, D.E. Schmechel, Rudolph E. Tanzi, James F. Gusella and Margaret A. Pericak‐Vance and has published in prestigious journals such as The Lancet, Neurology and Neuroscience Letters.

In The Last Decade

P. C. Gaskell

8 papers receiving 374 citations

Peers

Countries citing papers authored by P. C. Gaskell

Since Specialization

Citations

This map shows the geographic impact of P. C. Gaskell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. C. Gaskell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. C. Gaskell more than expected).

Fields of papers citing papers by P. C. Gaskell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. C. Gaskell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. C. Gaskell. The network helps show where P. C. Gaskell may publish in the future.

Co-authorship network of co-authors of P. C. Gaskell

This figure shows the co-authorship network connecting the top 25 collaborators of P. C. Gaskell. A scholar is included among the top collaborators of P. C. Gaskell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. C. Gaskell. P. C. Gaskell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	Longitudinal follow‐up of late‐onset Alzheimer disease families 2008 ·American Journal of Medical Genetics Part B Neuropsychiatric Genetics ·Regina M. Carney, Michael A. Slifer, Ping‐I Lin, P. C. Gaskell, William K. Scott, (unknown), Christine M. Hulette, Kathleen A. Welsh‐Bohmer, D. E. Schmechel, Jeffery M. Vance, Margaret A. Pericak‐Vance	1
2	No association of α1-antichymotrypsin flanking region polymorphism and Alzheimer disease risk in early- and late-onset Alzheimer disease patients 1998 ·Neuroscience Letters ·Meredyth P. Bass, Larry H. Yamaoka, William K. Scott, P. C. Gaskell, Kathleen A. Welsh‐Bohmer, Allen D. Roses, Ann M. Saunders, Jonathan L. Haines, Margaret A. Pericak‐Vance	2
3	A "liver test" is not a liver test. Measuring serum creatine kinase can identify muscular dystrophy and avoid liver biopsy. 1998 ·PubMed ·(unknown), P. C. Gaskell, Jeffrey M. Stajich	4
4	Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease 1996 ·The Lancet ·(unknown), Christine Hulette, (unknown), (unknown), Barbara J. Crain, James R. Burke, (unknown), (unknown), (unknown), C. Rosenberg, (unknown), P. C. Gaskell, MA Pericak-Vance, (unknown)	195
5	Linkage of frontotemporal dementia to chromosome 17: clinical and neuropathological characterization of phenotype. 1996 ·PubMed ·Larry H. Yamaoka, Kathleen A. Welsh‐Bohmer, Christine M. Hulette, P. C. Gaskell, Melissa E. Murray, (unknown), (unknown), Mariella Guerra, Allen D. Roses, D.E. Schmechel, Jeffery M. Vance	54
6	Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease 1995 ·Neurology ·Elizabeth H. Corder, Ann M. Saunders, Warren J. Strittmatter, D.E. Schmechel, P. C. Gaskell, Jacqueline Rimmler, P. A. Locke, P. M. Conneally, Ken Schmader, Rudolph E. Tanzi, James F. Gusella, G. W. Small, Allen D. Roses, Margaret A. Pericak‐Vance, J. L. Haines	138
7	Linkage analysis in familial Alzheimer disease: Description of the Duke and Boston data sets 1993 ·Genetic Epidemiology ·Margaret A. Pericak‐Vance, Peter St George‐Hyslop, P. C. Gaskell, John H. Growdon, Barbara J. Crain, Christine Hulette, James F. Gusella, Larry H. Yamaoka, Rudolph E. Tanzi, Allen D. Roses, J. L. Haines	5
8	SIB-PAIR LINKAGE ANALYSIS IN LATE ONSET ALZHEIMER??S DISEASE 1988 ·Alzheimer Disease & Associated Disorders ·Allen D. Roses, (unknown), (unknown), Deborah V. Dawson, (unknown), Ellen B. Kaplan, P. C. Gaskell, Albert Heyman, Chris M. Clark, Nancy L. Earl	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact